Change over period
From:
To:
Zoom:
- 1Y
- 3Y
- 5Y
- 10Y
- 15Y
- 20Y
- Max
CEO | Mr. Corey N. Fishman |
IPO Date | May 25, 2018 |
Location | Ireland |
Headquarters | Fitzwilliam Court, Dublin, Ireland, 2 |
Employees | 14 |
Sector | Healthcare |
Industry | Biotechnology |
Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and intravenous formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. The company was incorporated in 2015 and is headquartered in Dublin, Ireland.
NA
StockViz Staff
September 19, 2024
Any question? Send us an email